We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$440M
AUM Growth
+$9.07M
(+2.1%)
Cap. Flow
-$6.96M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
52.42%
Holding
87
New
10
Increased
20
Reduced
29
Closed
4
Top Buys
| 1 |
CMPS
Compass Pathways
CMPS
|
+$10.8M |
| 2 |
Nektar Therapeutics
NKTR
|
+$5.13M |
| 3 |
Larimar Therapeutics
LRMR
|
+$4.36M |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$2.76M |
| 5 |
Fulcrum Therapeutics
FULC
|
+$1.9M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
+$9.76M |
| 2 |
Axogen
AXGN
|
+$7.38M |
| 3 |
ATXS
Astria Therapeutics
ATXS
|
+$3.99M |
| 4 |
Revolution Medicines
RVMD
|
+$2.41M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.25M |
Sector Composition
| 1 | Healthcare | 87.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Foghorn Therapeutics
FHTX
$316M
| $535K | 0.12% |
111,859
-15,000
| -12% | -$82.3K |
|
77
iBio
IBIO
$73.5M
| $368K | 0.08% |
+193,638
| New | +$449K |
|
|
BCYC
78
Bicycle Therapeutics
BCYC
$294M
| $299K | 0.07% |
64,492
| – | – |
|
79
ADC Therapeutics
ADCT
$162M
| $270K | 0.06% |
72,081
-5,000
| -6% | -$19.7K |
|
80
Karyopharm Therapeutics
KPTI
$219M
| $255K | 0.06% |
45,800
-5,200
| -10% | -$39.6K |
|
|
AUTL
81
Autolus Therapeutics
AUTL
$397M
| $247K | 0.06% |
179,316
| – | – |
|
82
Neumora Therapeutics
NMRA
$304M
| $137K | 0.03% |
+70,000
| New | +$181K |
|
|
ATXS
83
DELISTED
Astria Therapeutics
ATXS
| – | – |
-304,775
| Closed | -$3.99M |
|
|
BWAY
84
Brainsway
BWAY
$604M
| – | – |
-25,930
| Closed | -$247K |
|
85
Perspective Therapeutics
CATX
$357M
| – | – |
-50,000
| Closed | -$138K |
|
86
Erasca
ERAS
$6.59B
| – | – |
-254,436
| Closed | -$947K |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML